Cited by 66Hormonal and reproductive studiesSperm and Testicular FunctionHypothalamic control of reproductive hormones

Management of Anabolic Steroid-Induced Infertility: Novel Strategies for Fertility Maintenance and Recovery

Open access
Tatem, Alexander J., Beilan, Jonathan, Kovac, Jason R., Lipshultz, Larry I.·2020·The World Journal of Men's Health

Abstract

There is often inherent conflict in the overlapping fields of male fertility and andrology. While the goal of all male fertility specialists is to facilitate and preserve biologic paternity, many practitioners also care for a significant number of patients suffering from hypogonadism. Exogenous testosterone administration, the gold standard for the management of these patients, almost universally impairs spermatogenesis and can even completely eradicate it in some men. With steady increases in both the incidence of hypogonadism and average paternal age, practitioners are now encountering hypogonadal men who desire future fertility or men suffering the effects of earlier androgenic anabolic steroid use with increasing frequency. In this manuscript, we review management strategies for these complex patients and explore novel medications that may be of use in this population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5534/wjmh.190002

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Long-term use of anabolic steroids is associated with increased risks of hepatic dysfunction, carcinoma, cardiovascular disease, prolonged testicular suppression, and subfertility.

    “While short-term use may lead to increased muscle mass, long-term use has been associated with increased risks of hepatic dysfunction, carcinoma, and cardiovascular disease, as well as prolonged testicular suppression and subfertility (33-35).”

    From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [34]

    The 'Mechanisms of Action > Androgenic anabolic steroids' section (page not supplied) describes cardiac and hepatic adverse effects, long-term hypogonadism after AAS use, and risks to future fertility. It does not mention carcinoma or establish that the cardiac and hepatic risks specifically increase with long-term use. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • hCG acts directly on the testis and is well-tolerated, but is expensive and requires multiple injections per week, leading many patients to elect alternative treatments.

    “While hCG acts directly on the testis and is well-tolerated, this medication is expensive, and with the requirement for multiple injections per week, many patients elect alternative treatments (34).”

    From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [34]

    The ‘Human chorionic gonadotropin’ section (page unavailable) says hCG acts directly on the testicle and that its cost, subcutaneous administration, and short half-life limit its use as primary therapy. The ‘Maintenance of fertility with concurrent testosterone use’ section describes every-other-day injections, supporting multiple injections per week. The copy does not state that hCG is well-tolerated or that many patients elect alternative treatments. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tatem, A. J., Beilan, J., Kovac, J. R., & Lipshultz, L. I.
Affiliations
  • Baylor College of Medicine (US)
  • Men's Health Center, Indianapolis, IN, USA.
Corresponding author
Lipshultz, Larry I.
Venue
The World Journal of Men's Health
Publisher
XMLink
Published
2020
Volume
38
Issue
2
Pages
141
ISSN
  • 2287-4208 (ISSN-L)
  • 2287-4690
OpenAlex
W2932790794
Cited by
66
References
75
Citations by year
2026: 9 · 2025: 6 · 2024: 8 · 2023: 13 · 2022: 11 · 2021: 9 · 2020: 6 · 2019: 3
FWCI
1.12
Type
journal article
Language
en
Open access
Locations
  • The World Journal of Men s Health (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
hypogonadism, exogenous testosterone, spermatogenesis, male fertility preservation, fertility restoration, anabolic steroids, paternal age

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review